United States HR 5894: Transparency in Prescription Drug Advertising Act

Status: Introduced in House (as of 2020-02-13)

State: United States · Session: 116 · Bill: HR 5894

Subjects: Drug safety, medical device, and laboratory regulation, Inflation and prices, Marketing and advertising, Prescription drugs

Sponsors: Sharice Davids, Abby Finkenauer, Ed Perlmutter, Elissa Slotkin

View United States HR 5894 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.